| Makale Türü |
|
||
| Dergi Adı | Medical Records | ||
| Dergi ISSN | 2687-4555 | ||
| Dergi Tarandığı Indeksler | TR DİZİN | ||
| Makale Dili | İngilizce | Basım Tarihi | 01-2024 |
| Cilt / Sayı / Sayfa | 6 / 1 / 44–49 | DOI | 10.37990/medr.1383719 |
| Makale Linki | http://dx.doi.org/10.37990/medr.1383719 | ||
| UAK Araştırma Alanları |
Fizyoloji
|
||
| Özet |
Material and Method: For the study, four groups were formed from H9c2 embryonic cardiomyocyte cells as Control, DOX (1 μM, 48 h), GOS25 (25 µg/ml, 48 h), and GOS50 (50 µg/ml, 48 h). In the study, Total antioxidant and oxidant status (TAS and TOS), levels of the inflammatory cytokines IL 1 beta and 6, and TNF α, lipid peroxidation levels as malondialdehyde (MDA), glutathione peroxidase (GSHPx), and glutathione (GSH) levels in the H9c2 embryonic cardiomyocyte cells were determined. Results: The results showed that DOX treatment caused cell toxicity in the embryonic cardiomyocyte cells and increased TOS, IL 1 beta and 6, TNF α, and MDA levels while decreasing TAS, GSH, and GSHPx levels. This situation improved with GOS treatment. Conclusion: As a result, it was determined that GOS treatment showed a protective effect in the DOX-induced cell toxicity model in H9c2 embryonic cardiomyocyte cell lines. |
| Anahtar Kelimeler |
| Oxidative stress | inflammation | H9c2 cardiomyocyte cell | gossypin | doxorubicin |
| Atıf Sayıları | |
| Google Scholar | 5 |